Annual CAPEX
$27.09 M
+$5.74 M+26.85%
31 December 2023
Summary:
NovoCure Limited annual capital expenditures is currently $27.09 million, with the most recent change of +$5.74 million (+26.85%) on 31 December 2023. During the last 3 years, it has risen by +$12.13 million (+81.01%). NVCR annual CAPEX is now at all-time high.NVCR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$10.68 M
-$763.00 K-6.67%
30 September 2024
Summary:
NovoCure Limited quarterly capital expenditures is currently $10.68 million, with the most recent change of -$763.00 thousand (-6.67%) on 30 September 2024. Over the past year, it has increased by +$3.43 million (+47.29%). NVCR quarterly CAPEX is now -25.16% below its all-time high of $14.27 million, reached on 31 December 2021.NVCR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$40.73 M
+$3.43 M+9.19%
30 September 2024
Summary:
NovoCure Limited TTM capital expenditures is currently $40.73 million, with the most recent change of +$3.43 million (+9.19%) on 30 September 2024. Over the past year, it has increased by +$14.03 million (+52.54%). NVCR TTM CAPEX is now at all-time high.NVCR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.9% | +47.3% | +52.5% |
| 3 y3 years | +81.0% | +224.0% | +160.2% |
| 5 y5 years | +303.7% | +294.5% | +341.7% |
NVCR CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +81.0% | -25.2% | +224.0% | at high | +160.2% |
| 5 y | 5 years | at high | +303.7% | -25.2% | +308.1% | at high | +341.7% |
| alltime | all time | at high | +1068.3% | -25.2% | +765.7% | at high | +2373.2% |
NovoCure Limited CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.68 M(-6.7%) | $40.73 M(+9.2%) |
| June 2024 | - | $11.45 M(-2.9%) | $37.30 M(+13.8%) |
| Mar 2024 | - | $11.78 M(+72.8%) | $32.79 M(+21.0%) |
| Dec 2023 | $27.09 M(+26.9%) | $6.82 M(-6.0%) | $27.09 M(+1.5%) |
| Sept 2023 | - | $7.25 M(+4.6%) | $26.70 M(+6.2%) |
| June 2023 | - | $6.93 M(+13.8%) | $25.15 M(+12.5%) |
| Mar 2023 | - | $6.09 M(-5.3%) | $22.35 M(+4.7%) |
| Dec 2022 | $21.36 M(-11.6%) | $6.43 M(+12.8%) | $21.36 M(-26.9%) |
| Sept 2022 | - | $5.70 M(+38.1%) | $29.20 M(+9.0%) |
| June 2022 | - | $4.13 M(-18.9%) | $26.80 M(+6.0%) |
| Mar 2022 | - | $5.09 M(-64.3%) | $25.28 M(+4.6%) |
| Dec 2021 | $24.17 M(+61.5%) | $14.27 M(+332.9%) | $24.17 M(+54.4%) |
| Sept 2021 | - | $3.30 M(+25.9%) | $15.65 M(+3.4%) |
| June 2021 | - | $2.62 M(-34.2%) | $15.14 M(-4.4%) |
| Mar 2021 | - | $3.98 M(-30.9%) | $15.84 M(+5.8%) |
| Dec 2020 | $14.97 M(+42.8%) | $5.76 M(+107.0%) | $14.97 M(+22.0%) |
| Sept 2020 | - | $2.78 M(-16.1%) | $12.26 M(+0.6%) |
| June 2020 | - | $3.31 M(+6.5%) | $12.19 M(+8.1%) |
| Mar 2020 | - | $3.11 M(+1.9%) | $11.27 M(+7.5%) |
| Dec 2019 | $10.48 M | $3.06 M(+12.8%) | $10.48 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $2.71 M(+13.0%) | $9.22 M(+17.2%) |
| June 2019 | - | $2.40 M(+3.1%) | $7.87 M(+13.6%) |
| Mar 2019 | - | $2.33 M(+29.7%) | $6.93 M(+3.2%) |
| Dec 2018 | $6.71 M(-8.9%) | $1.79 M(+32.5%) | $6.71 M(-2.2%) |
| Sept 2018 | - | $1.35 M(-7.2%) | $6.86 M(-5.5%) |
| June 2018 | - | $1.46 M(-30.8%) | $7.26 M(+3.2%) |
| Mar 2018 | - | $2.11 M(+8.3%) | $7.04 M(-4.4%) |
| Dec 2017 | $7.37 M(-58.3%) | $1.95 M(+11.0%) | $7.37 M(-16.4%) |
| Sept 2017 | - | $1.75 M(+42.1%) | $8.81 M(-25.9%) |
| June 2017 | - | $1.23 M(-49.3%) | $11.89 M(-31.1%) |
| Mar 2017 | - | $2.43 M(-28.3%) | $17.27 M(-2.2%) |
| Dec 2016 | $17.66 M(+72.0%) | $3.40 M(-29.7%) | $17.66 M(+1.6%) |
| Sept 2016 | - | $4.83 M(-27.0%) | $17.38 M(+15.0%) |
| June 2016 | - | $6.61 M(+133.8%) | $15.11 M(+32.0%) |
| Mar 2016 | - | $2.83 M(-9.1%) | $11.45 M(+11.5%) |
| Dec 2015 | $10.27 M(+342.9%) | $3.11 M(+21.4%) | $10.27 M(+43.4%) |
| Sept 2015 | - | $2.56 M(-13.1%) | $7.16 M(+55.8%) |
| June 2015 | - | $2.95 M(+79.1%) | $4.60 M(+179.1%) |
| Mar 2015 | - | $1.65 M | $1.65 M |
| Dec 2014 | $2.32 M(-36.1%) | - | - |
| Dec 2013 | $3.63 M | - | - |
FAQ
- What is NovoCure Limited annual capital expenditures?
- What is the all time high annual CAPEX for NovoCure Limited?
- What is NovoCure Limited annual CAPEX year-on-year change?
- What is NovoCure Limited quarterly capital expenditures?
- What is the all time high quarterly CAPEX for NovoCure Limited?
- What is NovoCure Limited quarterly CAPEX year-on-year change?
- What is NovoCure Limited TTM capital expenditures?
- What is the all time high TTM CAPEX for NovoCure Limited?
- What is NovoCure Limited TTM CAPEX year-on-year change?
What is NovoCure Limited annual capital expenditures?
The current annual CAPEX of NVCR is $27.09 M
What is the all time high annual CAPEX for NovoCure Limited?
NovoCure Limited all-time high annual capital expenditures is $27.09 M
What is NovoCure Limited annual CAPEX year-on-year change?
Over the past year, NVCR annual capital expenditures has changed by +$5.74 M (+26.85%)
What is NovoCure Limited quarterly capital expenditures?
The current quarterly CAPEX of NVCR is $10.68 M
What is the all time high quarterly CAPEX for NovoCure Limited?
NovoCure Limited all-time high quarterly capital expenditures is $14.27 M
What is NovoCure Limited quarterly CAPEX year-on-year change?
Over the past year, NVCR quarterly capital expenditures has changed by +$3.43 M (+47.29%)
What is NovoCure Limited TTM capital expenditures?
The current TTM CAPEX of NVCR is $40.73 M
What is the all time high TTM CAPEX for NovoCure Limited?
NovoCure Limited all-time high TTM capital expenditures is $40.73 M
What is NovoCure Limited TTM CAPEX year-on-year change?
Over the past year, NVCR TTM capital expenditures has changed by +$14.03 M (+52.54%)